Late-onset <i>NPM1</i> mutation in a MYC-amplified relapsed / refractory acute myeloid leukemia patient treated with gemtuzumab ozogamicin and glasdegib

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Haematologica

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Hematology

Show all topics

DOI

10.3324/haematol.2023.284922

License

CC-BY-NC

Other Formats

PDF